Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03003468
Title Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Lawrence Feldman, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Illinois at Chicago Chicago Illinois 60612 United States Details
Indiana Univeristy Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
University of Iowa Hospital and Clinics Iowa City Iowa 52242 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Penn State Cancer Institute Hershey Pennsylvania 17033 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field